Ireland’s Health and Safety Executive has criticised a new report revealing the country’s shocking last place in Western Europe for new oncology drug access.

IND application submission on track for Q2 2025: MBX 4291, a GLP-1/GIP co-agonist prodrug, is being developed as a once-monthly treatment for obesity. The Company expects to submit an IND application ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

ECONOMYNEXT – New active credit cards in Sri Lanka increased by 11,881 in March this year, the central bank data showed, amid ...